Michael R. Abern
Experienced in Bacterial Prostatitis

Dr. Michael R. Abern

Urology
Duke Health
Duke Cancer Center
20 Duke Medicine Cir, 
Durham, NC 
On Staff At
Clinical Trials:Currently Recruiting for 3 Trials
Accepting New Patients
Offers Telehealth
Experienced in Bacterial Prostatitis
Duke Health
Duke Cancer Center
20 Duke Medicine Cir, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I am a urologic oncologist who specializes in the diagnosis and surgical treatment of tumors of the urinary tract in men and women. I employ minimally invasive techniques as much as possible in order to maximize quality of life and recovery from treatment. Examples include robotic surgical removal of the prostate, kidney tumors, and bladder with complete robotic reconstruction. I am passionate about researching tests and treatments that will help my patients achieve cure of their cancers. I believe this starts with understanding risk factors for cancer to guide screening and early detection of tumors. I enjoy listening to my patients and understanding their goals of care. I believe that cancer care is a team sport and the patient is the captain. I collaborate with other specialists to make a comprehensive treatment plan including but not limited to surgery. In my free time, I enjoy exploring the outdoors with my wife and two daughters.

Dr. Abern is rated as an Experienced provider by MediFind in the treatment of Bacterial Prostatitis. His top areas of expertise are Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Bacterial Prostatitis.

Specialties
Urology
Licenses
Urology in NC
Board Certifications
American Board Of Urology, Urology
Fellowships
Urologic Oncology, Duke University
Hospital Affiliations
Duke Regional Hospital
Duke University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Duke Cancer Center
20 Duke Medicine Cir, Durham, NC 27710
Call: 919-681-6900

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Biological, Drug
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Recruiting
Publish Date: December 11, 2025
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Other
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
The Impact of a Gene Expression Profile on Treatment Choice and Outcome Among Minority Men Newly Diagnosed With Prostate Cancer: A Randomized Trial
The Impact of a Gene Expression Profile on Treatment Choice and Outcome Among Minority Men Newly Diagnosed With Prostate Cancer: A Randomized Trial
Enrollment Status: Completed
Publish Date: October 05, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

107 Total Publications

Comparing the Perioperative and Oncological Outcomes of Open Versus Minimally Invasive Inguinal Lymphadenectomy in Penile Cancer: A Systematic Review and Meta-Analysis.
Comparing the Perioperative and Oncological Outcomes of Open Versus Minimally Invasive Inguinal Lymphadenectomy in Penile Cancer: A Systematic Review and Meta-Analysis.
Journal: Cancers
Published: July 20, 2025
View All 107 Publications
Similar Doctors
Distinguished in Bacterial Prostatitis
Dr. Joseph C. Zola
Urology
Distinguished in Bacterial Prostatitis
Dr. Joseph C. Zola
Urology

Granville Health Inc

102 Professional Park, Suite C, 
Oxford, NC 
 (29.2 miles away)
919-692-0003
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Zola is an Urologist in Oxford, North Carolina. Dr. Zola is rated as a Distinguished provider by MediFind in the treatment of Bacterial Prostatitis. His top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Perirenal Abscess, Carbuncle, and Ureteroscopy. Dr. Zola is currently accepting new patients.

Advanced in Bacterial Prostatitis
Dr. Jason R. Rothman
Urology
Advanced in Bacterial Prostatitis
Dr. Jason R. Rothman
Urology

Triangle Urology Associates

205 Frasier Street, 
Durham, NC 
 (3.2 miles away)
919-470-4000
Experience:
23+ years
Languages Spoken:
English
See accepted insurances

Jason Rothman is an Urologist in Durham, North Carolina. Dr. Rothman has been practicing medicine for over 23 years and is rated as a Distinguished provider by MediFind in the treatment of Bacterial Prostatitis. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Prostatectomy.

Experienced in Bacterial Prostatitis
Dr. Joseph C. Allen
Urology
Experienced in Bacterial Prostatitis
Dr. Joseph C. Allen
Urology

Rex Hospital Inc

4420 Lake Boone Trl, 
Raleigh, NC 
 (18.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Allen is an Urologist in Raleigh, North Carolina. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Bacterial Prostatitis. His top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Kidney Stones, Boils, and Ureteroscopy. Dr. Allen is currently accepting new patients.

VIEW MORE BACTERIAL PROSTATITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Abern's expertise for a condition
ConditionClose
  • Elite
  • Prostate Cancer
    Dr. Abern is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Distinguished
  • Bladder Cancer
    Dr. Abern is
    Distinguished
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Renal Cell Carcinoma (RCC)
    Dr. Abern is
    Distinguished
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Advanced
  • Chromophobe Renal Cell Carcinoma
    Dr. Abern is
    Advanced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Abern is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Familial Prostate Cancer
    Dr. Abern is
    Advanced
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Familial Wilms Tumor 2
    Dr. Abern is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Muscle Invasive Bladder Cancer
    Dr. Abern is
    Advanced
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Nephrectomy
    Dr. Abern is
    Advanced
    . Learn about Nephrectomy.
    See more Nephrectomy experts
View All 15 Advanced Conditions
  • Experienced
  • Bacterial Prostatitis
    Dr. Abern is
    Experienced
    . Learn about Bacterial Prostatitis.
    See more Bacterial Prostatitis experts
  • Bilateral Hydronephrosis
    Dr. Abern is
    Experienced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Outlet Obstruction
    Dr. Abern is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Bladder Reconstruction
    Dr. Abern is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Bladder Stones
    Dr. Abern is
    Experienced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Choriocarcinoma
    Dr. Abern is
    Experienced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
View All 29 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.